In the latest quarter, higher costs were felt across the company’s vast health insurance operations.
Related Posts
F.D.A. Delays Action on Closely Watched Alzheimer’s Drug
Eli Lilly’s donanemab was expected to be approved this month, but the agency has decided to convene a panel of…
Americans Have Regained Modest Trust in Scientists, Survey Finds
A sharp partisan divide remains over how involved researchers should be in policy decisions.
Videos Show Ants Amputating Nest Mates’ Legs to Save Their Lives
The life of a Florida carpenter ant can be brutal. These half-inch ants are territorial and have violent bouts with…